摘要：目的：比较欣母沛与米索前列醇预防行剖宫产术的高危孕妇产后出血的临床效果。方法：选取2014年1月至2015年1月于我院择期行剖宫产术的112例高危孕妇为研究对象，将患者随机分为欣母沛组(56例)和米索前列醇组(56例)，欣母沛组采用欣母沛进行预防，米索前列醇组采用米索前列醇进行预防。观察两组患者产后出血发生率、产后2小时出血量、产后24小时出血量及不良反应发生情况。结果：欣母沛组患者产后出血发生率(25%)低于米索前列醇组(42.86%)，欣母沛组患者产后2小时出血量和产后24小时出血量均明显少于米索前列醇组，差异均具有统计学意义(P<0.05)。欣母沛组患者用药后不良反应发生率(17.86%)低于米索前列醇组(26.79%)，但差异无统计学意义(P>0.05)。结论：欣母沛预防行剖宫产术高危孕妇产后出血的效果优于米索前列醇，值得在临床上推广。

    关键词：欣母沛；米索前列醇；高危孕妇；剖宫产术；产后出血

    Abstract：Objective： To compare the clinical effect of hemabate and misoprostol for preventing postpartum hemorrhage. Methods： 112 cases of high-risk pregnant women who the palace produces the technique was included the study from 2014 January to 2015 January in our hospital. The cases were randomly divided into hemabate group (56 cases) and misoprostol group (56 cases). Hemabate group was treated with hemabate for prevention and misoprostol group was treated with misoprostol for prevention. Observes two groups of postpartum hemorrhage formation rate ......